Further evidence for botulinum toxin A in cerebral palsy.
Division of Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, Canada.
Vann
V
Chau
Division of Developmental Pediatrics, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada; Bloorview Research Institute, Toronto, Ontario, Canada.
Darcy
D
Fehlings
Division of Neurology, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, Canada; Neurosciences and Mental Health Program, SickKids Research Institute, Toronto, Ontario, Canada. Electronic address: steven.miller@sickkids.ca.
Steven P
SP
Miller
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A